Press-release for stocks

Prices are updated after-hours

meeting crawled time : 20:00

save search

Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
Published: 2024-04-19 (Crawled : 20:00) - globenewswire.com
OLK | News | $21.85 -1.89% -1.92% 590K

Manufacturing

| Email alert Add to watchlist
report olink meeting

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
LUMO | $2.57 -1.91% -1.95% 12K

Health Technology

| Email alert Add to watchlist
pharma presentation for medical

WK Kellogg Co to Host Annual Shareholders Meeting
Published: 2024-04-17 (Crawled : 20:00) - prnewswire.com
KLG | $21.22 -2.48% -0.99% 1.1M

| 0.0% | O: 0.0% H: 0.0% C: 0.0%
kellogg meeting

Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
CLNN S | $0.3492 5.85% 5.53% 1.2M

| Email alert Add to watchlist
au8 neurology sclerosis treatment for meeting

Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
THTX | $1.29 -12.78% 8.1K

Health Technology

| Email alert Add to watchlist
management meeting

GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
GNFT | $3.59 4.03% 2.1K

Health Technology

| 3.12% | O: -0.57% H: 3.71% C: 3.71%
meeting

Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Published: 2024-04-12 (Crawled : 20:00) - globenewswire.com
AQST | $4.11 -8.67% -9.49% 2.3M

Health Technology

| Email alert Add to watchlist
neurology for meeting therapeutics study

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -3.42% | O: 0.11% H: 0.38% C: -0.04%
meeting

Calavo Growers, Inc. Announces Virtual Access for its 2024 Annual Meeting of Shareholders
Published: 2024-04-10 (Crawled : 20:00) - globenewswire.com
CVGW | $28.43 6.16% 5.8% 210K

Consumer Non-Durables

| 2.65% | O: 0.98% H: 0.32% C: 0.0%
for meeting

Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
MURA | $3.55 -0.56% -0.56% 240K

| -14.39% | O: -1.2% H: 1.94% C: 0.0%
il-18 association cancer research preclinical for meeting il-12

Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024
Published: 2024-04-09 (Crawled : 20:00) - prnewswire.com
FUSN | $21.26 0.05% 0.05% 440K

Health Technology

| -0.65% | O: -0.19% H: 0.28% C: 0.09%
fpi-2265 presentation pharmaceuticals meeting trial

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
STTK | $9.58 -5.43% -5.74% 420K

Health Technology

| 11.33% | O: -1.11% H: 9.78% C: 9.66%
association presentation cancer research preclinical for meeting

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
Published: 2024-04-08 (Crawled : 20:00) - globenewswire.com
CRDF | $4.34 -0.69% -0.69% 610K

Health Services

| -25.68% | O: 0.85% H: 5.73% C: -4.55%
ongoing preclinical meeting study

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-08 (Crawled : 20:00) - globenewswire.com
IPSC | $3.06 2.86% 2.78% 110K

Professional, Scientific, and T...

| -24.87% | O: -1.59% H: 8.87% C: 7.8%
association cancer cell research preclinical for meeting technology therapeutics therapy platform

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
PRCT A | $50.155 -1.81% -1.84% 550K

Manufacturing

| 13.25% | O: 0.52% H: 5.55% C: 2.33%
biorobotics meeting

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
RXST | $51.6 -0.29% -0.29% 240K

| 1.6% | O: -0.5% H: 9.3% C: 6.61%
rxsight light meeting commercial

QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
Published: 2024-04-03 (Crawled : 20:00) - globenewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M

Health Technology

| -6.39% | O: -1.05% H: 0.8% C: -0.87%
QGEN | $40.0 1.34% 0.0% 1.1M

Health Technology

| -6.39% | O: -1.05% H: 0.8% C: -0.87%
cancer meeting

Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
SGHT | $5.14 -1.91% -1.95% 130K

| -2.21% | O: 6.8% H: 2.07% C: -9.98%
sciences meeting trial results

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
ZNTL | $12.97 3.43% 3.32% 1M

Health Technology

| -18.63% | O: -6.85% H: 7.84% C: 7.35%
pharmaceuticals preclinical meeting

Veru Announces Date of 2024 Annual Meeting of Shareholders
Published: 2024-04-01 (Crawled : 20:00) - globenewswire.com
VERU | $1.305 -8.1% -8.81% 2.6M

Health Technology

| 96.54% | O: 5.05% H: 2.77% C: 2.0%
meeting